RavenQuest BioMed Inc (CNSX:RQB) (OTCMKTS:RVVQF) (FRA:1IT) CEO George Robinson joins Midas Letter in-studio to discuss the company’s formal definitive agreement with Biocare partners for all RavenQuest’s joint venture operations located in Europe. The companies will construct cannabis cultivation facilities with planned capacity to produce 35,000 kilograms of medical cannabis initially in Portugal. The CEO also outlines the recent research partner announcement with McGill University. The license obtained from Health Canada allows for the possession and production of cannabis for research purposes. The CEO also explains the economics of the company’s trademark Orbital Garden technology, stating the company is in position to take a run at anyone in terms of cost and efficiency. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our 2nd YouTube Channel - Midas Letter Clips: https://bit.ly/2rtQzgy SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************ #WeedStocks #MidasLetter
Originally posted on RavenQuest BioMed Inc (CNSX:RQB) Industry Leading Grow Technology & Formalizing European Operations via George Scorsis Medical Marijuana News
No comments:
Post a Comment